搜索临床试验以:阿扎那韦/利托那韦+奥美拉唑
总计1763个结果
-
Boehringer Ingelheim终止
-
National Health Research Institutes, Taiwan完全的
-
SanofiBristol-Myers Squibb完全的
-
AbbVie (prior sponsor, Abbott)完全的
-
Main Line HealthAstraZeneca; Sharpe-Strumia Research Foundation; Cancer Research Foundation of America未知
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); Food and Drug... 和其他合作者完全的
-
SanofiBristol-Myers Squibb完全的
-
Kaohsiung Veterans General Hospital.Kaohsiung Medical University Chung-Ho Memorial Hospital完全的
-
ANRS, Emerging Infectious DiseasesUniversity Hospital, Geneva招聘中
-
First Affiliated Hospital of Zhejiang UniversityAscletis Pharmaceuticals Co., Ltd.完全的
-
AbbVie完全的慢性丙型肝炎 | 丙型肝炎病毒 (HCV) | 丙型肝炎基因型 1a
-
University of California, San FranciscoNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)完全的
-
Azienda Ospedaliera Universitaria Integrata VeronaAgenzia Italiana del Farmaco; Azienda Sanitaria-Universitaria Integrata di Udine完全的
-
AbbVie完全的慢性丙型肝炎 | 丙型肝炎病毒 (HCV) | 丙型肝炎基因型 1a
-
Odense University HospitalAstraZeneca; University of Southern Denmark; The Danish Medical Research Council; Danish College... 和其他合作者完全的
-
Tibotec Pharmaceuticals, Ireland完全的
-
Kowa Research Europe完全的
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang Gung Memorial Hospital 和其他合作者完全的
-
Vecta Ltd.完全的
-
Icahn School of Medicine at Mount SinaiNational Center for Complementary and Integrative Health (NCCIH); National Center for Research...完全的
-
Tel-Aviv Sourasky Medical Center未知
-
AstraZeneca完全的